Evidence of Support for Improved Cervical Cancer Prevention ... - RHO

More documents

Recommendations

Info

Mexico DECLARATION of the MEETING TOWARDS COMPREHENSIVE CERVICAL CANCER PREVENTION AND CONTROL Mexico City 12-13 May, 2008 Recognizing that cervical cancer is one of the most common causes of death among women in Latin America and the Caribbean (LAC); That 33,000 women die each year of cervical cancer in Latin America and the Caribbean. That it is estimated that, if this trend continues, the number of deaths from cervical cancer will double by 2030. That it primarily affects vulnerable populations such as poor women and indigenous populations. Expressing concern for the high burden of this disease, with the highest mortality rates in the world and its economic impact in Latin America and Caribbean. That now we know HPV causes virtually 100% of cervical cancers. That today there are vaccines against HPV, which offer great hope towards the prevention of 70% of the infections by this virus. That the primary limitation for its use is the high cost. That vaccines against HPV do not replace screening programs, diagnostics and treatment. That with the introduction of this vaccine we have an opportunity to strengthen prevention and comprehensive control through improving coverage and quality of screening, diagnostics, and treatment services. The participants resolve to: Promote the integration among programs responsible for immunization, cancer prevention and control, and adolescent and reproductive health with the goal of strengthening efforts toward the prevention and control of cervical cancer. Take the opportunity with the introduction of the vaccine against HPV to strengthen sexual and reproductive education, training of personnel, as well as cancer screening services, diagnostics and treatment. Continue considering immunization programs as a regional public good with high political priority. Consider the introduction of a vaccine against HPV based on technical, programmatic and operational criteria of individual countries, taking into consideration the need to strengthen the cold chain, epidemiological surveillance systems, and the laboratory network in countries. Work together and with PAHO's Revolving Fund to obtain affordable prices for HPV vaccines so that all the countries in the region can introduce the vaccine in their national immunization programs as soon as possible. Generate mechanisms and negotiating processes with high-level financing stakeholders at the national level, which will ensure the sustainability of vaccination programs, prevention and control of cervical cancer. Country Participants Argentina Barbados Brazil Canada Chile Colombia Costa Rica Cuba Dominican Republic Ecuador El Salvador Guatemala Honduras Jamaica México Nicaragua Panamá Paraguay Peru United States Venezuela
United Kingdom Fédération Internationale de Gynécologie et d’Obstétrique International Federation of Gynecology and Obstetrics Secretariat: FIGO House Suite 3, Waterloo Court, 10 Theed St, London SE1 8ST United Kingdom Telephone: +44 20 7928 1166 Fax: +44 20 7928 7099 Email: figo@figo.org Website: http://www.figo.org To Cervical Cancer Action: The International Federation of Gynecology and Obstetrics (FIGO) is submitting this letter to express our Federation’s strong support for rapid global access to comprehensive programmes to protect girls and women from cervical cancer. This terrible disease which causes so much pain and suffering hits the low resource countries particularly hard. Approximately 85 % of cervical cancer deaths occur in low resource countries and these deaths can tear the fabric of the family and put additional pressure on scarce, local resources. In some places it is common for these women to be caretakers of children left orphaned by HIV and other diseases. Many deaths resulting from cervical cancer could be avoided if all girls and women were given timely access to improved screening and treatment, along with the possibility of future vaccination. We share your commitment that access to new technologies should follow disease not wealth. It is crucial that the costs of HPV vaccine and new screening technologies be reduced and access increased as quickly as possible. We stand ready to work in partnership with the global community to make these tools available appropriately and effectively to the girls and women who need them most. Dorothy Shaw President FIGO is incorporated under the Swiss Civil Code and established at 42 rue du 31 Decembre, Geneva, Switzerland President:: Professor D Shaw (Canada), Vice-President:: Dr S Zaidi (Pakistan), President-Elect:: Professor G Serour (Egypt), Past-President: Professor A Acosta (Paraguay), Honorary Treasurer: Associate Professor J Liljestrand (Sweden), Honorary Secretary: Professor I Fraser (Australia) 10
Page 1: Evidence of Support for Improved Ce
Page 4 and 5: PORTAL / SALA DE PRENSA VIRTUAL AÑ
Page 6 and 7: Contents Africa Letters • 219 sig
Page 8 and 9: Contents continued Articles • Bra
Page 10 and 11: Uganda
Page 12 and 13: Peru PORTAL / SALA DE PRENSA VIRTUA
Page 14 and 15: United States
Page 16 and 17: Tanzania
Page 20 and 21: Vietnam SOCIALIST REPUBLIC OF VIETN
Page 22 and 23: Nigeria To whom it may concern: I a
Page 24: 15 Switzerland

Evidence of Support for Improved Cervical Cancer Prevention ... - RHO

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?